Clinical implementation of PLANET ® Dose for dosimetric assessment after [ 177 Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0

ConclusionsThe ADs to organs at risk obtained with the new workstation PLANET ® Dose are concordant with those calculated with the currently used software and in agreement with the literature. These results validate the use of PLANET® Dose in clinical routine for patient dosimetry after targeted radiotherapy with [177Lu]Lu-DOTA-TATE.

http://link.springer.com/10.1186/s13550-020-00737-8

Source: EJNMMI Research - January 4, 2021 Category: Radiology Source Type: research